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Abstract
Background: When advising patients on diet and health, the general practitioner (GP) makes judgements based on
the evidence available. Since current evidence on diet and cardiovascular disease is conflicted and confusing, we
surveyed the current consensus amongst GPs. The aim of this study was to determine the views of GPs on dietary
saturated fat, carbohydrates and long chain omega-3 fatty acids in the management of cardiovascular disease.
Method: An online questionnaire inviting participants to comment on seven contentious statements on diet and
cardiovascular disease. Questionnaire circulated to the 1800 members of South West Thames Faculty of the Royal
College of General Practitioners (RCGP). Participants were invited to tick “Agree”, “Disagree” or “Not sure” and were
encouraged to add comments for each question. The results were analysed with a combination of statistical
analysis and thematic analysis of comments.
Results: There were 89 responses. Most GPs seem well aware that drug treatment alone is inadequate and
that dietary advice is important. However, there was considerable disagreement about the roles of saturated
fats and carbohydrates in cardiovascular disease and “Not sure” responses ranged from 12 to 40.7%. The 40.
7% related to a statement on long chain omega-3 fatty acids. Analysis of comments revealed more opinions
including an awareness of the need to warn patients about trans-fatty acids.
Conclusions: Although the GP response rate was poor, responders do seem to see dietary advice as part of
their role but do not consider themselves as experts. Education in this area should have a higher priority.
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How this fits
General practitioners need to give advice on nutrition,
diet and health, especially cardiovascular health con-
cerns. There has been concern that medical school gives
little if any time to these issues. This survey shows that
there is a good deal of confusion in this area and our
data suggest that most knowledge is gained through
experience working in primary care.
Background
The average general practitioner (GP) in the United
Kingdom (UK) will have received very little education at
medical school on the role of nutrition in health and dis-
ease [1–3], but should be well versed in Pharmacology as a
prescribing doctor. In a recent survey [2], only 33% of med-
ical school academics felt that they were providing adequate
teaching on nutrition and health. Therefore, GPs may feel
more confident in providing advice on drug therapy rather
than diet for the prevention of cardiovascular disease
(CVD). However, an experienced GP may have acquired in-
formation about diet and lifestyle through their professional
experience. Current controversies over the relevance of free
sugars (as opposed to endogenous sugars in fruit (fructose)
and milk (lactose)) and fats to the aetiology of CVD [4–6]
has caused confusion amongst the general public [7, 8] and
we wondered what the consensus was amongst GPs. Also,
since 2013, the National Institute for Health and Care Ex-
cellence (NICE) clinical guidelines have de-emphasised the
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role of long chain omega-3 fatty acids in the management
of CVD and advise against routine prescribing of omega-3
acid ethyl esters (Omacor) [9]. However, NICE continue to
recommend an increase in dietary fish as part of a Mediter-
ranean diet [9]. There is a substantial body of evidence for
benefits to both primary and secondary cardiovascular
health from long chain omega-3 [10–13], and an equally
impressive body of evidence that has influenced NICE to be
cautious [14–16]. A 2017 study lasting 19 years has shown
a lower CVD death rate (hazard ratio 0.73) in subjects tak-
ing a long term regular daily dose of a long chain omega-3
fatty acid supplement [17].
The aim of our study was to assess the views of GPs on
a range of issues relating to nutrition and cardiovascular
disease by measuring their response to several emotive
and contentious questions about diet and health.
Methods
A survey monkey questionnaire was sent by email to
1800 GPs in the SW Thames section of the RCGP. One
follow-up reminder was sent with a link to the question-
naire as recommended by Pealer et al. [18]. This was
followed by asking non-responders to complete the same
questionnaire at an NHS Clinical Commissioning Group
(CCG) meeting for all GPs in the Guildford and Waverly
area of Surrey (approximately 6% of SW Thames GPs).
The questions were framed as tests of opinion rather
than tests of knowledge with tick box options “Agree”,
“Disagree” and “Not sure”. Participants were also en-
couraged to add comments and the comments were ana-
lysed using thematic analysis.
Questions:
1. Once you start a patient on a statin, diet isn’t very
important.
2. Omega 3 intake is key to recovery from a cardiac
event.
3. LDL cholesterol is more important than HDL
cholesterol when interpreting a lipid profile.
4. The latest evidence on dietary fat means that we
can now advise that it is safe to consume saturated
fat-rich foods.
5. Diet and dyslipidaemia are linked to dysfunction of
the endothelium.
6. Non-alcoholic fatty liver disease is a major risk
factor for cardiovascular disease.
7. Dietary carbohydrates are neutral with respect to
cardiovascular disease.
Statistics
The completed questionnaires were analysed using chi-
squared foursome tables to determine differences be-
tween internet responders and non-responders and
calculate p values. IBM SPSS Statistics software was
used to analyse gender differences, significance of years
in general practice using the student t-test and correl-
ation coefficients to show any correlations between
different components of the questionnaire and to calcu-
late p values for this data. An analysis of respondents’
comments was made for recurrent themes.
Results
A total of 89 GPs responded to the initial questionnaire
and a further 19 non-responders completed the ques-
tionnaire at the CCG meeting. The total sample was
108, which was 6% of the targeted GPs.
There were 74 (68.5%) female GPs and 33 (30.5%)
male GPs. Although age was not recorded for partici-
pants the number of years in general practice was re-
corded. The significance of age and experience was
reflected in this data (Additional file 1: Appendix 1). The
mean number of years in general practice was 13.7 yrs.
(range 0.5–42) and for male GPs average was 17.6 yrs.
(range 2–42) and for female GPs average was 12 yrs.
(range 0.5–33). This data was similar to regional data for
age and gender for GPs in South England although there
was a slight bias in favour of female GPs responding to
the questionnare which failed to reach statistical signifi-
cance (Additional file 2: Appendix 2).
The combined results are summarised in Table 1.
There was no statistically significant difference between
internet responders and non-responders. However there
was a trend for Question 2 with a greater proportion of
non-responders disagreeing with the statement “Omega
3 intake is key to recovery from a cardiac event”: Re-
sponders disagreed 30/89 (33.7%) Non responders dis-
agreed 10/19 (52.6%), p = 0.076. Responders were twice
as likely to respond “Not sure” than non-responders:
Responders “not sure” 40/89 (44.9%) and non-re-
sponders “not sure” 4/19 (21.1%), p = 0.054.
Table 1 Summary of results from questionnaire
Questions Agree Disagree Not sure
1. Diet is unimportant for patients
on statins
3 (2.8%) 105
(97.2%)
0 (0%)
2. Omega-3 relevant to
cardiac events
24 (22.2%) 40 (37%) 44
(40.7%)
3. LDL more important than HDL 49 (45.4%) 42 (38.9%) 17
(15.7%)
4. Dietary saturated fat safe 18 (16.7%) 57 (52.8%) 33
(30.6%)
5. Endothelial dysfunction
and dyslipidaemia
80 (74.1%) 3 (2.8%) 26
(24.1%)
6. NAFLD major risk factor for CVD 77 (71.3%) 6 (5.6%) 26
(24.1%)
7. Dietary carbohydrates neutral
for CVD
11 (10.2%) 84 (77.8%) 13 (12%)
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There was a trend for female GPs to be more likely to
chose “Not sure” responses (Table 2), but this was only
statistically significant for Question 4 which suggested
that dietary saturated fat is now considered “safe”. 78.8%
of male GPs disagreed with this statement, whereas only
41.9% of female GPs disagreed and 35% were “Not sure.”
There was a trend for years in practice as a GP to be a
factor in responses to the statements about omega-3 and
cardiac events, interpretation of lipid profiles and non-
alcoholic fatty liver disease with responses from younger
GPs reflecting their lack of experience (Table 3). There
was a degree of overlap between questions which did
not reach statistical significance: 42.6% disagreed that
dietary carbohydrates are neutral for CVD and disagreed
that it is now safe to advise saturated fat rich food and
42.6% agreed that diet & dyslipidaemia are linked to
endothelial dysfunction and were of the opinion that
dietary saturated fat is not safe.
Although there was an even split for statement 3 on
the relative importance of HDL and LDL cholesterol
with 15.7% of respondents opting for “not sure” (Table 1),
5.6% added the comment that the HDL/cholesterol ratio
is more significant.
Subjects were invited to add comments to all ques-
tions and at the end of the questionnaire. There were
37 comments that varied from very brief such as “in
moderation” for the question on safety of saturated
fats, to longer detailed comments on the role of nutri-
tion science in primary care. Comments of 4 words or
less that conveyed little or no meaning, were excluded
(5/37). Comments that could be classified thematically
(32/37) tended to come from respondents who had
been GPs a little longer (Table 4).
From a total of 32 such comments, the commonest
comment (10/32) was an acknowledgement that a
wide range of nutrients are important to cardiovascu-
lar health, and that a pharmacological approach alone
is inadequate. Comments that are representative ex-
amples of each type of response are summarised in
Table 5.
Discussion
Summary
Comments by participants (Table 5) seem to show a genu-
ine interest in dietary factors that influence cardiovascular
disease (CVD). Most GPs (97%) were well aware that diet is
of crucial importance in the control of CVD (Tables 1 and
5). However, there was considerable confusion about cer-
tain aspects of this topic with 44% being “Not sure” about
the role of omega-3 in recovery from cardiovascular events,
and 33% being unsure what advice they should be giving on
the safety of saturated fats in the diet (35% for female GPs).
The lack of teaching on nutritional science in medical
schools is illustrated by some responses from new recruits
to general practice (Tables 3 and 4).
The uncertainty and doubts about the evidence regarding
the heart and long chain omega-3 supplementation is illus-
trated by a response to the Question 2; “Omega-3 is key to
recovery from a cardiac event” with the comment: “If it
was, why was it taken off prescriptions?”, whereas others
were impressed with the evidence for the anti-arrhythmic
and anti-thrombotic activity of dietary long chain omega-3
fatty acids. Although controversial, there is good evidence
for the anti-arrhythmic and anti-thrombotic properties of
Table 2 Gender trend for response: not sure
Questions Female
(n = 74)
Female
%
Male
(n = 33)
Male
%
1. Statins more important
than diet
0 0% 0 0%
2. Omega-3 relevant to
cardiac events
34b 45.9% 9b 27.3%
3. LDL more important
than HDL
11 14.9% 6 18.2%
4. Dietary saturated fat safe 26a 35.1% 6a 18.2%
5. Endothelial dysfunction &
dyslipidaemia
21 28.4% 4 12.1%
6. NAFLD major risk factor
for CVD
17 24.2% 8 23.0%
7. Dietary carbohydrates neutral
for CVD
11 14.9% 2 6.1%
aSignificant gender difference at p < 0.05
bBorderline non-significant gender difference at p = 0.07
Table 3 Years as a GP influence on responses
Question
numbers
p values
Q3 Omega-3 relevant
to cardiac events
“Agree” sub-group had been
mean of 5 yrs. longer as a GP
than “Disagree” sub-group
0.17
Q2 LDL more
important than
HDL
“Unsure” sub-group had been
mean of 6 yrs. longer as a GP
than “Agree” and “Disagree”
combined
0.057
Q5 Dyslipidaemia
linked to
endothelial
dysfunction
“Disagree” (n = 3) were recent
recruits to GP with mean of
5.8 yr. as a GP
0.15
Q6 NAFLD major risk
factor for CVD
“Disagree” (n = 6) were recent
recruits to GP with mean of
6.9 yrs. as a GP
0.1
Questions
1, 4, 7
Years as GP were
not significant
–
Table 4 Number of years as a GP Versus type of comment or
no comment
Type of
comments:
N Mean years as a
GP
Std.
Deviation
Std. Error
Mean
None or insignificant 76 13.2 9.7196 1.1149
Significant 32 15.1 11.1773 1.9759
χ2 test: p = 0.038
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long chain omega-3 fatty acids [10–13]. However, there was
an impression of general confusion rather than an informed
consensus on this issue amongst these GPs.
While dietary trans-fatty acids were not mentioned in
the questionnaire, six GPs commented on the import-
ance of these fatty acids as a risk factor for CVD. There
was some agreement on the role of dietary free sugars
and saturated fats in CVD with 42.6% of GPs disagree-
ing with both the statement that dietary saturated fat is
safe (Q4), and that dietary carbohydrates are neutral for
CVD (Q7). Several comments highlighted the import-
ance of the differences between free sugars (as a CVD
risk factor) and complex carbohydrates, with the latter
being generally viewed as being beneficial to cardiovas-
cular health.
The split vote on the relative importance of LDL choles-
terol and HDL cholesterol, probably reflects the current
state of knowledge and confusion over the questionable
clinical relevance of raised HDL cholesterol. However one
participant suggested that the circulating level of VLDL
(very low density lipoprotein) is more significant than either
LDL or HDL. This may well be relevant to patients with
cardiometabolic risk factors who are at risk of developing
metabolic syndrome and type 2 diabetes mellitus and in
whom serum LDL cholesterol is unremarkable. Although
VLDL is not generally available for testing in primary care,
estimation of 12 h fasting triacylglycerol (also termed
triglycerides) is available and would be as reliable as VLDL
as an indicator of cardiometabolic risk [19].
The overall outcome of this survey provides evidence
of a body of professional doctors who have vested inter-
est in diet and health. However, as several GPs indicated,
their knowledge of the topic is inadequate and this may
apply especially in the early stages of their career.
Strengths and limitations
Strengths of this study include canvassing of grass
roots GPs who are dealing with the issue of diet and
CVD regularly. The main weakness of the study is the
poor response rate to the initial e-mailed online survey
monkey with only 89 (5.9% of targeted group) respond-
ing. However, this response rate is fairly typical for
mailings to members of the RCGP. A recent election
for places on the college council got an 8.4% response
(personal communication from Professor Kamila Haw-
thorne). While these responders may represent a select
group of GPs with a greater interest in nutrition, there
was very little difference between the responders and
the 19 non-responders. An exception was that more
responders disagreed about the value of long chain
omega-3 fatty acids for recovery from a cardiac event
than non-responders (52.6% versus 33.7%, p = 0.076).
Responders were twice as likely to opt for “Not sure”
for this statement.
Table 5 Analysis of participant’s comments
Topic of comments Number of
comments
Questions
comments related to
One good representative example of comments from this category
General value of diet in
cardiovascular health.
10 Q1 and final
comment
Even if it has less effect on lipids than the statin, diet is still
important in other areas of cardiovascular health.
Trans fatty acids an
important risk factor.
7 Qs 3, 4, 5 and
final comment
Excess saturated fat, cholesterol and trans-fats all increase the risk
of CVD.
Refined sugar an important
risk factor
7 Qs 4, 7 and final
comments
Complex carbohydrates have a beneficial effect and refined sugar
the opposite.
HDL/cholesterol ratio is the
best guide
6 Q3 Both HDL and LDL are equally relevant. The ratio between them is
important.
References to diet and
metabolic syndrome
5 Qs 6, 7 and final
comments
Carbohydrates are negative in that they contribute to the metabolic
syndrome and DM
Low GI diet is beneficial 3 Q7 A high GI diet has been shown to be a risk factor for CVD
Sugar can be converted
to fat
3 Q7 High intake of refined sugar leads to dyslipidaemia with sugar
converted to fat
GPs need more nutrition
knowledge
3 Final comments I wish we doctors had more access to education related to nutrition
Advise patients to eat more
plant foods
2 Q4 The main source of fats should be plant rather than animal derived.
High homocysteine is a risk
factor for CVD
1 Final comments Excess protein in the diet is an important risk factor, especially excess
methionine from cheese. It leads to high homocysteine levels.
VLDL cholesterol is an
important risk factor
1 Q3 LDL is more important than HDL but VLDL cholesterol is even more so.
Role of omega-3 in prevent
ing CVD deaths
1 Q2 Omega 3 is anti-thrombotic and anti-arrhythmic. Synthetic supplements
have been disappointing.
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Comparison with existing literature
Previous research in this area is limited to the teaching
of nutritional science for medical students and associ-
ated academic departments [1–3], but tends to be in
accord with the impression from this trial that teaching
of nutritional science both in medical school and after
medical school is inadequate.
Implications for future research
To get an accurate assessment of the needs of GPs in rela-
tion to teaching on nutrition and health, a larger sample is
needed. However, adequate coverage of this topic could be
ensured by starting with focus groups to determine the
best questions and format to use for any future research.
Conclusions
GPs see dietary advice as part of their role, but do not
consider themselves as experts. Despite the poor re-
sponse rate, the value of this paper is that it can inform
those designing diet/CVD related interventions for GP
settings as it highlights information needs of GPs and
maybe also practice nurses who are likely to deliver most
of this care. The uncertainty about the interpretation of
the nutrition science that underlies many of the diet-re-
lated issues that GPs experience could, perhaps, be recti-
fied by raising the profile of nutrition on the curriculum
in medical schools [1, 2].
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